Atom now has a strategic foothold in dual therapeutic areas of metabolism and cardiovascular diseases, strengthening its core competitive edge.
At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback